Apoptosis in cancer: from pathogenesis to discovery of advanced selective Bcl-2 family inhibitors

Samaa Abbas, Nermin Abdou, Deena Lasheen, Dalal Abou El Ella
2019 Archives of Pharmaceutical Sciences Ain Shams University  
Cancer is a genetic disease characterized by two features: unregulated cell growth and tissue invasion (metastasis). It can be viewed as the result of a succession of genetic changes during which a normal cell is transformed into a malignant one. Evasion of cell death, apoptosis, is one of the essential changes in a cell that cause this malignant transformation. Hence, reduced apoptosis or its resistance plays a vital role in carcinogenesis. The Bcl-2 family of proteins regulates the
more » ... al apoptotic pathway. Disease states arise upon deregulation of the Bcl-2 family of proteins, where cell death is either promoted or evaded; one of the most common tactic cancer cells utilize to promote survival is anti-apoptotic protein overexpression. Specifically, Bcl-2 overexpression has been shown to be a major chemoresistance factor in a number of human cancers, and for this reason, Bcl-2 targeting is a pharmacologic priority in the quest to reactivate cell death for therapeutic benefit in cancer.
doi:10.21608/aps.2019.20225 fatcat:uypzpqgfk5bvrarsvvzbwki5dm